Neurogene Inc. (NGNE)

NASDAQ: NGNE · Real-Time Price · USD

15.33

-1.90 (-11.03%)

At close: Nov 20, 2024, 4:00 PM

15.05

-0.28 (-1.83%)

Pre-market: Nov 21, 2024, 7:16 AM EST

Neurogene Employees

Neurogene had 91 employees as of December 31, 2023. The number of employees increased by 9 or 10.98% compared to the previous year.

Employees

91

Change (1Y)

9

Growth (1Y)

10.98%

Revenue / Employee

$10,165

Profits / Employee

-$36,000

Market Cap

199.19M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	91	9	10.98%
Dec 31, 2022	82	-	-

Related Stocks

Company Name	Employees
Zynex	1,100
Anika Therapeutics	357
Poseida Therapeutics	330
Fate Therapeutics	181
Mersana Therapeutics	123
Ocugen	65
Artiva Biotherapeutics	43
Eton Pharmaceuticals	30

Employee Rankings

NGNE News

22 hours ago - Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
1 day ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Neurogene Inc. (NGNE) And Encourages Investors to Connect - Accesswire
2 days ago - Neurogene Reports Third Quarter 2024 Financial Results and Highlights Recent Updates - Business Wire
2 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Neurogene Inc. (NGNE) And Encourages Stockholders to Connect - Accesswire
3 days ago - Neurogene Provides Update on NGN-401 Gene Therapy Clinical Trial for Rett Syndrome - Business Wire
3 days ago - Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire
5 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Neurogene Inc. (NGNE) and Encourages Stockholders to Learn More About the Investigation - Accesswire
6 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Neurogene Inc. (NGNE) Investors to Inquire about Securities Investigation - Accesswire